-
-
-
-
-
-
-
Tempus AI shares initial results from multimodal foundation model for oncology
-
-
-
-
-
-
-
Lucent Diagnostics partners with Tempus AI for Alzheimer's blood testing
-
-
-
-
-
-
-
Legendary Investors are Rotating Capital into AI Powered Biotech
-
-
-
-
-
-
-
Tempus launches AI-driven cancer algorithm for treatment selection
-
-
-
-
-
-
-
Tempus AI reports record contract value exceeding $1.1 billion
-
-
-
-
-
-
-
Tempus AI (TEM) call put ratio 2.9 calls to 1 put into quarter results
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $95 at Guggenheim
-
420,184 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

